Standex director plans sale of 50 shares

Standex International Corp (SXI) director Thomas E. Chorman has filed a Form 144 notice covering the proposed sale of 50 shares of Standex common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 09/01/2026.

Rhea-AI Filing Summary

Standex International Corp (SXI) director Thomas E. Chorman has filed a Form 144 notice covering the proposed sale of 50 shares of Standex common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 09/01/2026. The shares to be sold were acquired from the issuer via restricted stock vesting on 10/26/2024 as compensation. The filing also reports prior open-market sales by Chorman of 50 shares each on 06/01/2026, 07/01/2026, and 08/03/2026, at aggregate prices of $13,641.00, $17,775.50, and $15,278.00, respectively.

Key Figures

Shares to be sold: 50 shares Approximate date of sale: 09/01/2026 Date of acquisition: 10/26/2024 +3 more

6 metrics

Shares to be sold 50 shares Proposed Rule 144 sale of Standex common stock

Approximate date of sale 09/01/2026 Planned timing of Rule 144 sale

Date of acquisition 10/26/2024 Restricted stock vesting that delivered the 50 shares

Prior sale on 06/01/2026 $13,641.00 for 50 shares Sale of Standex common shares during past 3 months

Prior sale on 07/01/2026 $17,775.50 for 50 shares Sale of Standex common shares during past 3 months

Prior sale on 08/03/2026 $15,278.00 for 50 shares Sale of Standex common shares during past 3 months

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 10/26/2024 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Thomas Chorman"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"10/26/2024 | Compensation"

FAQ

What does the Form 144 filing disclose for STANDEX INTERNATIONAL CORP (SXI)?

It discloses that director Thomas E. Chorman plans to sell 50 shares of Standex common stock through Fidelity Brokerage Services LLC, with an approximate sale date of 09/01/2026, under Rule 144 resale provisions.

How many SXI shares is Thomas E. Chorman planning to sell under this Form 144?

Thomas E. Chorman is planning to sell 50 shares of Standex International Corp common stock. These shares are part of his existing holdings and are being registered for potential resale under Rule 144.

When and how did Thomas E. Chorman acquire the SXI shares he plans to sell?

The 50 shares to be sold were acquired on 10/26/2024 via restricted stock vesting from Standex International Corp, and the filing identifies the nature of acquisition as compensation from the issuer.

What prior SXI share sales by Thomas E. Chorman are reported in the last three months?

The filing lists three prior sales of 50 shares each on 06/01/2026 for $13,641.00, 07/01/2026 for $17,775.50, and 08/03/2026 for $15,278.00.

Who is executing the planned SXI share sale for Thomas E. Chorman?

The planned sale of 50 shares of Standex common stock is to be executed through Fidelity Brokerage Services LLC, which is listed as the broker in the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 11:29 AM Accepted by SEC EDGAR 09/01/2026 - 11:28 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001248847
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	STANDEX INTERNATIONAL CORP/DE/
SEC File Number	001-07233
Address of Issuer	23 KEEWAYDIN DRIVE SUITE 300 SALEM NEW HAMPSHIRE 03079
Phone	603-893-9701
Name of Person for Whose Account the Securities are To Be Sold	CHORMAN THOMAS E
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	50	14244.50	12119465	09/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/26/2024	Restricted Stock Vesting	Issuer			50	10/26/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Thomas Chorman 23 Keewaydin Drive Salem NH 03079	Common	06/01/2026	50	13641.00
Thomas Chorman 23 Keewaydin Drive Salem NH 03079	Common	07/01/2026	50	17775.50
Thomas Chorman 23 Keewaydin Drive Salem NH 03079	Common	08/03/2026	50	15278.00

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas Chorman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)